Prolactin Blood Test: Normal Ranges & Causes | Peptide Chats
Research information only. Not medical advice. 18+ only. Not FDA-approved for human therapeutic use.

Prolactin blood test

Prolactin. Also called: PRL

Biomarker guideLast updated: October 29, 2026

Prolactin is the pituitary hormone behind milk production. A high result has many harmless causes, including stress, sleep, pregnancy and common medications, so it is read alongside how and when the blood was drawn.

LOINC 2842-3HormonesSexual

At a glance

What it measuresProlactin, a pituitary hormone best known for starting and maintaining milk production.
SampleBlood (serum). Labcorp lists no fasting; Quest prefers an overnight fast.
Typical adult rangeDepends on sex and lab. Labcorp, ages 31-50: men 3.9-22.7 ng/mL, women 4.8-33.4 ng/mL.
Common reasons it reads highStress of the draw, recent sleep, pregnancy and breastfeeding, dopamine-blocking drugs, low thyroid, kidney failure, macroprolactin, prolactinoma.
Peptides that move itRaised briefly after each dose by GHRP-2, Hexarelin and Macimorelin. Ipamorelin and Tesamorelin did not change it.
Lab codeLOINC 2842-3 (Labcorp 004465, Quest 746)

What is Prolactin?

Prolactin is a 23 kDa protein hormone of 199 amino acids, made mainly by lactotroph cells in the anterior pituitary. Its main job is in pregnancy and breastfeeding: developing the mammary glands and making and maintaining milk.

Labs measure it as the first test for unexplained milk production (galactorrhea) and to look for prolactin-secreting pituitary tumors.

Sources: [1] [2]

How it is made and regulated

Where it is made

Lactotrophs make up about 20% of the cells of the anterior pituitary and secrete prolactin. Other tissues can also make it, which complicates the picture of what it does.

Sources: [3] [4]

What controls it

Control is mainly inhibitory: dopamine from the hypothalamus holds prolactin release down, and prolactin feeds back on its own secretion. TRH and VIP both stimulate release. Secretion comes in pulses, is highest during sleep, and the night-time rise depends on sleep itself.

Sources: [1] [5] [6] [3] [7]

How it travels in the blood

Prolactin acts by binding the prolactin receptor on cell surfaces, which signals mainly through the JAK-STAT pathway. In some people much of the circulating prolactin is "macroprolactin": prolactin bound to antibodies, too large to leave the bloodstream and biologically weak, which builds up because it is cleared slowly.

Sources: [4] [8]

How long it lasts

Circulating prolactin has a half-life of 20-50 minutes and is cleared by the liver and kidneys.

Sources: [3]

What it does

Beyond milk production, prolactin has roles in reproduction, insulin-producing islet cells, fat cells and the immune system. Too much prolactin mainly causes hypogonadotropic hypogonadism (suppressed reproductive hormones), which in women most often shows up as irregular or absent periods.

Sources: [4] [9]

Reference ranges

Each lab sets its own ranges for its own assay, so the two tables below do not match. Women run higher than men, and pregnancy raises prolactin many-fold. Use the range printed on your report.

Labcorp (test 004465)

Method: Electrochemiluminescence immunoassay (ECLIA). Labcorp test page (retrieved October 29, 2026).

GroupRange (ng/mL)
Males, 13 to 30 years3.6-31.5
Females, 13 to 30 years4.8-33.4
Males, 31 to 50 years3.9-22.7
Females, 31 to 50 years4.8-33.4
Males, 51 to 80 years3.6-25.2
Females, 51 to 80 years3.6-25.2
Males, Over 80 years3.6-32.0
Females, Over 80 years3.6-32.0
Children and teens
GroupRange (ng/mL)
Males, 0 to 30 days4.3-32.8
Females, 0 to 30 days4.5-24.4
Males, 1 to 6 months5.4-51.4
Females, 1 to 6 months5.4-51.4
Males, 7 months to 1 year5.3-28.9
Females, 7 months to 1 year4.8-33.4
Males, 2 to 12 years1.8-44.2
Females, 2 to 12 years4.8-33.4

Serum preferred; lithium-heparin plasma accepted (not oxalate, EDTA or citrate plasma).

Quest Diagnostics (test 746)

Method: Immunoassay (IA). Quest Diagnostics test page (retrieved October 29, 2026).

GroupRange (ng/mL)
Adult males2.0-18.0
Adult females, not pregnant3.0-30.0
Adult females, pregnant10.0-209.0
Adult females, postmenopausal2.0-20.0
Children and teens
GroupRange (ng/mL)
Girls, Tanner stage I3.6-12.0
Girls, Tanner stages II-III2.6-18.0
Girls, Tanner stages IV-V3.2-20.0
Boys, Tanner stage I10.0 or lower
Boys, Tanner stages II-III6.1 or lower
Boys, Tanner stages IV-V2.8-11.0

Ranges as shown for Quest's East service area. The directory prints the Tanner stage I range for girls as "3.6.12.0"; it is shown here as 3.6-12.0.

Labcorp gives ranges by age and sex but none for pregnancy; Quest gives adult ranges by sex, pregnancy and menopause, and Tanner-stage ranges for children.

Sources: [2] [10]

What raises it

FactorHowHow much
PregnancyPhysiologyProlactin rises steadily through pregnancy as the lactotroph cells grow in size and number.From an average of 30 ng/mL in the first trimester to 200 ng/mL at term (first radioimmunoassay study) [1] [11]
Breastfeeding (suckling)PhysiologySuckling triggers rapid prolactin release through a nerve-to-hormone reflex.Some 10- to 20-fold rise in serum prolactin [1] [11]
SleepPhysiologyProlactin peaks during sleep, typically between 4 and 6 AM, and the night-time rise depends on sleep itself.No published magnitude [7] [3]
Stress, including the blood drawLifestylePhysical or psychological stress raises prolactin; fear of the needle can cause a short-lived rise.Stress-induced rises are usually mild to moderate, between 20 and 100 ng/mL [3] [12]
Dopamine-blocking medicationsMedicationAntipsychotics and drugs such as metoclopramide block the dopamine signal that holds prolactin down. The rise depends on the drug and dose and is larger in women.Usually under 100 ng/mL; risperidone and metoclopramide can push it above 200 ng/mL [13] [9] [2]
Underactive thyroidConditionHypothyroidism raises prolactin; treating the thyroid usually brings it back down.Median 60 ng/mL in 62 patients with thyroid-related hyperprolactinemia; raised in 21.3% of newly diagnosed overt and 8% of subclinical hypothyroidism in another study [14] [15]
Kidney failureConditionProlactin is cleared partly by the kidneys and runs high in end-stage kidney disease; more frequent dialysis did not lower it.Median 65 ng/mL in patients on hemodialysis; 81% above 30 ng/mL [16] [3]
ProlactinomaConditionA prolactin-secreting pituitary tumor, the most frequent cause of chronic hyperprolactinemia.A level above 250 ng/mL makes a prolactinoma likely; 500 ng/mL or more is diagnostic of a macroprolactinoma [9]
MacroprolactinConditionAntibody-bound prolactin is cleared slowly and is picked up by the test, so the result reads high even though the extra prolactin is largely inactive.Reported in 15-46% of people with high prolactin [8]
Prolactin-releasing peptidesPeptideTRH, VIP and several GH secretagogues stimulate prolactin release. See the peptide table below.VIP: peak 28.1 vs 11.4 ng/mL with saline [6]

What lowers it

FactorHowHow much
Dopamine agonistsMedicationBromocriptine and cabergoline mimic dopamine and are the mainstay of treatment for high prolactin; in 1972 bromocriptine reduced raised prolactin and stopped milk production in 5 patients.No published magnitude [9] [17]
AripiprazoleMedicationUnlike most antipsychotics, higher aripiprazole doses were associated with lower prolactin.No published magnitude [13]
Treating an underactive thyroidMedicationThyroid hormone replacement removes the stimulus to prolactin in hypothyroidism.High prolactin fully resolved in 70.4% and improved in 18.5% of patients after thyroid treatment [14]
Pituitary damageConditionDiseases that destroy pituitary tissue cause low prolactin levels.No published magnitude [2]
SecretinPeptideAn IV secretin infusion lowered prolactin in women. See the peptide table below.No published magnitude [18]

Peptides that affect Prolactin

How each peptide in our library has been shown to affect prolactin, strongest evidence first. Most rises are short-lived responses to a single dose. "No clear effect" means prolactin was measured and did not change; "Unclear" means the results conflict.

PeptideEffect on ProlactinSize of effectEvidence
AdrenomedullinRaisesRose from 197 to 372 IU/L (P < 0.01) during a high-dose IV infusion (13.4 pmol/kg/min, over 40 times normal blood levels)ACTH, TSH, FSH, LH and cortisol did not change. [19]Human trials
AviptadilRaisesPeak 28.1 vs 11.4 ng/mL with saline, 15 minutes after 200 µg intramuscularly (normal women)Aviptadil is synthetic VIP; the study gave VIP, which also raised prolactin above 120% of baseline in all 5 patients with prolactinoma tested. [6]Human trials
BombesinRaisesProlactin rose in 6 of 8 healthy men during a 60-minute infusion (10 ng/kg/min)GH, LH and parathyroid hormone did not change. [20]Human trials
Enkephalin (Met-enkephalin / Leu-enkephalin)RaisesNo published magnitude in the abstract (enkephalin analogue DAMME)Tested with the enkephalin analogue DAMME (0.25 mg IV) in 6 men: prolactin and GH rose significantly, then returned to control levels while the drug was still detectable. [21]Human trials
GalaninRaisesDuring a 60-minute IV infusion basal prolactin did not rise significantly (peak 12.2 vs 8.7 µg/L), but it stopped the fall seen with saline (area under the curve 1216.6 vs 672.0 µg·min/L, P < 0.05)In 6 young women galanin also enhanced the prolactin response to TRH and arginine, but not to metoclopramide. [22]Human trials
GhrelinRaisesNo pooled figure published (review of 121 studies)A review of 121 studies (1,850 participants) found strong evidence that giving ghrelin raises prolactin, along with GH, ACTH, cortisol and glucose. [23]Human trials
Ghrelin AcetateRaisesRose quickly, peaking 15-30 minutes after 1 µg/kg IV in 10 healthy women; a smaller rise than after TRHGiving ghrelin and TRH together did not add to the TRH response. [24]Human trials
GHRP-2RaisesRose after 1-2 µg/kg IV in 6 young adults, by less than after TRHGHRP-2 and hexarelin raised prolactin, ACTH and cortisol to a similar extent, so they are not fully GH-specific. [25]Human trials
HexarelinRaisesPer dose: up to a 180% rise from baseline (IV, dose-dependent); no sustained rise at 16 weeks of twice-daily injections (area under the curve 624 vs 641 mU/L·h, P = 0.35)The prolactin response to an IV dose was not reduced after a day of repeated injections. Prolactin rose with GHRP-2 and hexarelin less than with TRH. [26] [27] [28] [25]Human trials
MacimorelinRaisesMaximum median rise of 100 mU/L (P = 0.004) after a single oral dose (0.5 or 0.75 mg/kg) in 28 healthy volunteersOral GH secretagogue approved as a single-dose test for adult GH deficiency. [29]Human trials
MK-677 (Ibutamoren)RaisesPer dose: raised after the first dose, less after repeated doses; in obese men the area under the curve (not the peak) stayed raised at 2 and 8 weeksOral GH secretagogue (ibutamoren). In two 7-8-day studies (dieting adults; GH-deficient children) prolactin did not differ from placebo or baseline. [30] [31] [32]Human trials
SermorelinRaisesA small, short-lived rise (P < 0.05) after one 1 µg/kg IV dose of GHRH 1-29 in 20 short childrenSermorelin is GHRH(1-29). The rise was minor next to its GH effect. [33]Human trials
Thyrotropin-Releasing Hormone (TRH)RaisesPeak 35.2-48.5 ng/mL after 200 µg IV in 20 women, higher in the luteal phase; during a 5-hour infusion in men, prolactin peaked at 40 minutes and then fell despite continued TRHA strong prolactin-releasing signal; Labcorp lists a TRH stimulation test among the provocative tests used in working up high prolactin. [5] [34] [2]Human trials
Vasoactive Intestinal Peptide (VIP)RaisesPeak 28.1 vs 11.4 ng/mL with saline, 15 minutes after 200 µg intramuscularly (normal women)VIP also raised prolactin above 120% of baseline in all 5 patients with prolactinoma tested. [6]Human trials
SecretinLowersFell significantly during an IV infusion (2.0 CU/kg/h) in the follicular and luteal phases; not significant at midcycle (8 women)The authors attribute the follicular-phase fall to secretin itself. [18]Human trials
OxytocinNo clear effectNo change in basal prolactin after 1 IU IV (6 women) or oral oxytocin 50 IU three times daily for 7 days after delivery (9 women)Milk output was not affected either. [35]Human trials
TesamorelinNo clear effectNo clinically significant changes in prolactin in clinical trials (Egrifta SV label)FDA-approved GHRH analog. Its label also reports no change in TSH, LH or ACTH. [36]FDA label
IpamorelinNo clear effectNo change in plasma prolactin in swineA selective GH secretagogue: unlike GHRP-6 and GHRP-2, it also did not raise ACTH or cortisol. No human prolactin data have been published. [37]Animal studies
GHRP-6UnclearNo release in normal rats; release only in GH-deficient female dwarf ratsIn rats GHRP-6 (0.1-2.5 µg IV) did not release prolactin in normal males or females; it did in GH-deficient female dwarf rats, an effect that depended on estrogen. No human prolactin data for GHRP-6 alone were found. [38]Animal studies

What high or low results can mean

A high result

A mildly high result is common and often has a harmless cause; a very high result points toward a prolactinoma.

  • Stress of the blood draw, or a sample taken soon after waking
  • Pregnancy or breastfeeding
  • Dopamine-blocking medications such as antipsychotics or metoclopramide
  • Underactive thyroid or kidney failure
  • Macroprolactin (antibody-bound, largely inactive prolactin)
  • A prolactin-secreting pituitary tumor (prolactinoma)

Next step: Discuss it with a clinician. Repeating the test at rest, reviewing medications, checking thyroid and kidney function and testing for macroprolactin (PEG precipitation) usually come before pituitary imaging.

Sources: [9] [3] [39] [14]

A low result

A low result can reflect damage to the pituitary gland, and is read alongside the other pituitary hormones.

  • Damage to the pituitary
  • Dopamine agonist treatment

Next step: Discuss it with a clinician, especially if other pituitary hormones are also low.

Sources: [2] [9]

How the test works

SampleSerum (preferred) or lithium-heparin plasma at Labcorp, which does not accept oxalate, EDTA or citrate plasma; 1 mL of serum in a serum separator tube at Quest.
FastingLabcorp lists no fasting requirement; Quest says an overnight fast is preferred. With high-dose biotin (over 5 mg a day), Labcorp asks for at least 8 hours after the last dose before the sample is taken.
TimingProlactin is released in pulses and peaks during sleep (typically 4-6 AM), so the result depends on when the sample is taken. The stress of the needle can raise it: in 150 patients, a pooled sample from 0, 30 and 60 minutes read lower than the first draw.
Lab differencesProlactin immunoassays vary because they react differently to monomeric prolactin and macroprolactin. Results above the reference interval are routinely checked for macroprolactin by PEG precipitation, and post-PEG prolactin is the most suitable way to report them.
RetestingProlactin varies a lot within one person: monthly samples over a year showed a within-person variation of 39.2%. Under controlled 24-hour sampling, mean levels in the same men differed by 2.8-19.6% between sessions.
Labcorp order code004465: Prolactin
Quest Diagnostics order code746: Prolactin
LOINC codes
  • 2842-3: Prolactin [Mass/volume] in Serum or Plasma
  • 20568-2: Prolactin [Mass/volume] in Serum or Plasma by Immunoassay (immunoassay-specific code)
LOINC 2842-3 on loinc.org

Sources: [2] [10] [40] [3] [12] [1] [39] [41] [42]

History

Human growth hormone is itself strongly lactogenic, which made prolactin hard to measure separately. The first specific assays (1970-1971) told the two apart, and a drug to lower prolactin followed within two years.

  1. 1970Frantz and Kleinberg use a mouse breast-tissue bioassay to show prolactin activity in human blood that growth hormone antiserum cannot neutralize, in postpartum women and patients with galactorrhea. [43]
  2. 1971Kleinberg and Frantz measure human prolactin in plasma by bioassay, finding it raised in nursing mothers, galactorrhea and patients on phenothiazine drugs. [44]
  3. 1971Hwang, Guyda and Friesen publish the first radioimmunoassay for human prolactin: normal adults usually below 30 ng/mL, rising to 200 ng/mL by the end of pregnancy. [11]
  4. 1972Besser and colleagues report that brom-ergocryptine (bromocriptine) lowers raised prolactin and stops inappropriate milk production in 5 patients. [17]
  5. 1973Sassin, Frantz and colleagues show that the night-time rise of human prolactin depends on sleep. [7]

FAQ

Do I need to fast before a prolactin test?

Labcorp lists no fasting requirement, while Quest says an overnight fast is preferred. If you take high-dose biotin (over 5 mg a day), Labcorp asks you to wait at least 8 hours after your last dose.

Sources: [2] [10]

What time of day should the blood be drawn?

Prolactin peaks during sleep, typically between 4 and 6 AM, and Labcorp notes that the result depends on when the sample was taken. A sample taken soon after waking can read higher than one taken later in the morning.

Sources: [3] [2]

Can the stress of the blood draw raise prolactin?

Yes. Stress, including fear of the needle, can raise prolactin into the 20-100 ng/mL range. In one study of 150 patients, a sample pooled from draws over an hour read lower than the first draw, so a borderline result is often repeated at rest.

Sources: [3] [12]

Why might my prolactin be high?

Common causes include pregnancy and breastfeeding, dopamine-blocking medications, an underactive thyroid, kidney failure and macroprolactin, as well as a prolactin-secreting pituitary tumor. Medications usually keep the rise under 100 ng/mL.

Sources: [9] [14] [16]

What level suggests a pituitary tumor?

A prolactin above 250 ng/mL makes a prolactinoma likely, and 500 ng/mL or more is diagnostic of a large one (macroprolactinoma). Lower elevations have many other causes, so imaging decisions are made with a clinician.

Sources: [9]

What is macroprolactin?

It is prolactin bound to antibodies, too large to leave the bloodstream and largely inactive, so it can make a test read high without causing symptoms. It is reported in 15-46% of people with high prolactin and is checked with PEG precipitation.

Sources: [8] [39]

Can medications raise prolactin?

Yes. Most antipsychotics raise prolactin in a dose-related way, more in women, while aripiprazole tends to lower it. Risperidone and metoclopramide can push prolactin above 200 ng/mL.

Sources: [13] [9]

Does thyroid disease affect prolactin?

An underactive thyroid can raise it. In a review of thyroid-related cases, treating the thyroid fully resolved the high prolactin in 70.4% of patients, without needing dopamine agonist drugs.

Sources: [14]

Can peptides raise prolactin?

Several GH-releasing peptides raise prolactin for a short time after each dose: GHRP-2, Hexarelin and Macimorelin did in human studies. Hexarelin did not cause a sustained rise over 16 weeks, and Ipamorelin and Tesamorelin did not change prolactin.

Sources: [25] [26] [29] [27] [37] [36]

Is prolactin different in men and women?

Yes, women run higher. Labcorp's range for ages 31-50 is 3.9-22.7 ng/mL in men and 4.8-33.4 ng/mL in women.

Sources: [2]

How high does prolactin go in pregnancy and breastfeeding?

It rises steadily through pregnancy, from about 30 ng/mL in the first trimester to about 200 ng/mL at term, and suckling raises it some 10- to 20-fold. Quest's range for pregnant women is 10.0-209.0 ng/mL.

Sources: [11] [10]

How much does prolactin vary between tests?

A lot. In healthy volunteers sampled monthly for a year, prolactin varied by 39.2% within the same person. That is why a single borderline result is usually repeated before anything else is done.

Sources: [41]

References

  1. Saleem M, Martin H, Coates P. Prolactin Biology and Laboratory Measurement: An Update on Physiology and Current Analytical Issues. Clin Biochem Rev. 2018;39(1):3-16. PMID 30072818
  2. Labcorp. Test 004465: Prolactin. Reference intervals, specimen requirements, methodology, limitations and LOINC map. labcorp.com/tests/004465/prolactin
  3. Levine S, Muneyyirci-Delale O. Stress-Induced Hyperprolactinemia: Pathophysiology and Clinical Approach. Obstet Gynecol Int. 2018;2018:9253083. PMID 30627169
  4. Gorvin CM. The prolactin receptor: Diverse and emerging roles in pathophysiology. J Clin Transl Endocrinol. 2015;2(3):85-91. PMID 29204371
  5. Boyd AE, Sanchez-Franco F. Changes in the prolactin response to thyrotropin-releasing hormone (TRH) during the menstrual cycle of normal women. J Clin Endocrinol Metab. 1977;44(5):985-9. PMID 404311
  6. Kato Y, Shimatsu A, Matsushita N, et al. Role of vasoactive intestinal polypeptide (VIP) in regulating the pituitary function in man. Peptides. 1984;5(2):389-94. PMID 6089138
  7. Sassin JF, Frantz AG, Kapen S, et al. The nocturnal rise of human prolactin is dependent on sleep. J Clin Endocrinol Metab. 1973;37(3):436-40. PMID 4361974
  8. Kasum M, Oreskovic S, Zec I, et al. Macroprolactinemia: new insights in hyperprolactinemia. Biochem Med (Zagreb). 2012;22(2):171-9. PMID 22838183
  9. Majumdar A, Mangal NS. Hyperprolactinemia. J Hum Reprod Sci. 2013;6(3):168-75. PMID 24347930
  10. Quest Diagnostics. Test code 746: Prolactin. Test directory entry (East service area): methodology, specimen, patient preparation, reference ranges and LOINC. testdirectory.questdiagnostics.com/test/test-detail/746/prolactin?cc=PHP
  11. Hwang P, Guyda H, Friesen H. A radioimmunoassay for human prolactin. Proc Natl Acad Sci U S A. 1971;68(8):1902-6. PMID 5288775
  12. Das M, Gogoi C. Pool vs single sample determination of serum prolactin to explore venipuncture associated stress induced variation. Sci Rep. 2023;13(1):113. PMID 36596817
  13. Lin X, Siafis S, Tian J, et al. Antipsychotic-Related Prolactin Changes: A Systematic Review and Dose-Response Meta-analysis. CNS Drugs. 2025;39(10):937-947. PMID 40830715
  14. Khan AA, Sharma R, Ata F, et al. Systematic review of the association between thyroid disorders and hyperprolactinemia. Thyroid Res. 2025;18(1):1. PMID 39754184
  15. Goel P, Kahkasha, Narang S, et al. Evaluation of serum prolactin level in patients of subclinical and overt hypothyroidism. J Clin Diagn Res. 2015;9(1):BC15-7. PMID 25737975
  16. Lo JC, Beck GJ, Kaysen GA, et al. Hyperprolactinemia in end-stage renal disease and effects of frequent hemodialysis. Hemodial Int. 2017;21(2):190-196. PMID 27774730
  17. Besser GM, Parke L, Edwards CR, et al. Galactorrhoea: successful treatment with reduction of plasma prolactin levels by brom-ergocryptine. Br Med J. 1972;3(5828):669-72. PMID 4675488
  18. Holst N, Jenssen TG, Burhol PG, et al. Prolactin response to secretin during the spontaneous menstrual cycle in women. Gynecol Obstet Invest. 1991;31(1):37-41. PMID 1672662
  19. Meeran K, O'Shea D, Upton PD, et al. Circulating adrenomedullin does not regulate systemic blood pressure but increases plasma prolactin after intravenous infusion in humans: a pharmacokinetic study. J Clin Endocrinol Metab. 1997;82(1):95-100. PMID 8989240
  20. Pontiroli AE, Alberetto M, Restelli L, et al. Effect of bombesin and ceruletide on prolactin, growth hormone, luteinizing hormone, and parathyroid hormone release in normal human males. J Clin Endocrinol Metab. 1980;51(6):1303-5. PMID 7440696
  21. Gilchrist N, Bolton JE, Donald RA, et al. Hormonal effects and metabolic clearance rate of the enkephalin analogue DAMME in man. Br J Clin Pharmacol. 1983;16(5):465-9. PMID 6315038
  22. Grottoli S, Arvat E, Gianotti L, et al. Galanin positively modulates prolactin secretion in normal women. J Endocrinol Invest. 1996;19(11):739-44. PMID 9061507
  23. Garin MC, Burns CM, Kaul S, et al. Clinical review: The human experience with ghrelin administration. J Clin Endocrinol Metab. 2013;98(5):1826-37. PMID 23533240
  24. Messini CI, Dafopoulos K, Chalvatzas N, et al. Effect of ghrelin and thyrotropin-releasing hormone on prolactin secretion in normal women. Horm Metab Res. 2010;42(3):204-8. PMID 19844859
  25. Arvat E, di Vito L, Maccagno B, et al. Effects of GHRP-2 and hexarelin, two synthetic GH-releasing peptides, on GH, prolactin, ACTH and cortisol levels in man. Comparison with the effects of GHRH, TRH and hCRH. Peptides. 1997;18(6):885-91. PMID 9285939
  26. Massoud AF, Hindmarsh PC, Brook CG. Hexarelin-induced growth hormone, cortisol, and prolactin release: a dose-response study. J Clin Endocrinol Metab. 1996;81(12):4338-41. PMID 8954038
  27. Rahim A, O'Neill PA, Shalet SM. The effect of chronic hexarelin administration on the pituitary-adrenal axis and prolactin. Clin Endocrinol (Oxf). 1999;50(1):77-84. PMID 10341859
  28. Maccario M, Veldhuis JD, Broglio F, et al. Impact of two or three daily subcutaneous injections of hexarelin, a synthetic growth hormone (GH) secretagogue, on 24-h GH, prolactin, adrenocorticotropin and cortisol secretion in humans. Eur J Endocrinol. 2002;146(3):310-8. PMID 11888836
  29. Urwyler SA, Lustenberger S, Drummond JR, et al. Effects of oral macimorelin on copeptin and anterior pituitary hormones in healthy volunteers. Pituitary. 2021;24(4):555-563. PMID 33615399
  30. Svensson J, Lönn L, Jansson JO, et al. Two-month treatment of obese subjects with the oral growth hormone (GH) secretagogue MK-677 increases GH secretion, fat-free mass, and energy expenditure. J Clin Endocrinol Metab. 1998;83(2):362-9. PMID 9467542
  31. Murphy MG, Plunkett LM, Gertz BJ, et al. MK-677, an orally active growth hormone secretagogue, reverses diet-induced catabolism. J Clin Endocrinol Metab. 1998;83(2):320-5. PMID 9467534
  32. Codner E, Cassorla F, Tiulpakov AN, et al. Effects of oral administration of ibutamoren mesylate, a nonpeptide growth hormone secretagogue, on the growth hormone-insulin-like growth factor I axis in growth hormone-deficient children. Clin Pharmacol Ther. 2001;70(1):91-8. PMID 11452249
  33. Gelander L, Lindstedt G, Selstam G, et al. Effects of acute intravenous injection of two growth hormone-releasing hormones (GHRH 1-40 and 1-29) on serum growth hormone and other pituitary hormones in short children with pulsatile growth hormone secretion. Horm Res. 1989;31(5-6):213-20. PMID 2515143
  34. Mongioì A, Aliffi A, Vicari E, et al. Down-regulation of prolactin secretion in men during continuous thyrotropin-releasing hormone infusion: evidence for induction of pituitary desensitization by continuous TRH administration. J Clin Endocrinol Metab. 1983;56(5):904-7. PMID 6403571
  35. del Pozo E, Kleinstein J, Brun del Re R, et al. Failure of oxytocin and lysine-vasopressin to stimulate prolactin release in humans. Horm Metab Res. 1980;12(1):26-8. PMID 7188925
  36. EGRIFTA SV (tesamorelin) for injection, prescribing information. DailyMed. dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=3d783378-b02d-4f19-99dd-0fc91a042224
  37. Raun K, Hansen BS, Johansen NL, et al. Ipamorelin, the first selective growth hormone secretagogue. Eur J Endocrinol. 1998;139(5):552-61. PMID 9849822
  38. Carmignac DF, Bennett PA, Robinson IC. Effects of growth hormone secretagogues on prolactin release in anesthetized dwarf (dw/dw) rats. Endocrinology. 1998;139(8):3590-6. PMID 9681512
  39. Šostarić M, Bokulić A, Marijančević D, et al. Optimizing laboratory defined macroprolactin algorithm. Biochem Med (Zagreb). 2019;29(2):020706. PMID 31223260
  40. LOINC 2842-3: Prolactin [Mass/volume] in Serum or Plasma. Regenstrief Institute. Record checked through the NLM Clinical Table Search Service. loinc.org/2842-3
  41. Maes M, Mommen K, Hendrickx D, et al. Components of biological variation, including seasonality, in blood concentrations of TSH, TT3, FT4, PRL, cortisol and testosterone in healthy volunteers. Clin Endocrinol (Oxf). 1997;46(5):587-98. PMID 9231055
  42. Partsch CJ, Lerchl A, Sippell WG. Characteristics of pulsatile and circadian prolactin release and its variability in men. Exp Clin Endocrinol Diabetes. 1995;103(1):33-43. PMID 7621103
  43. Frantz AG, Kleinberg DL. Prolactin: evidence that it is separate from growth hormone in human blood. Science. 1970;170(3959):745-7. PMID 5529569
  44. Kleinberg DL, Frantz AG. Human prolactin: measurement in plasma by in vitro bioassay. J Clin Invest. 1971;50(8):1557-68. PMID 5107095

Educational information, not medical advice. Lab ranges and test codes were checked on October 29, 2026. Always use the range printed on your own report, and talk to a clinician about your results.